Neurotoxicity associated with a reaction to sulphasalazine
Wallace, I.W.
Practitioner 204(224): 850-851
1970
ISSN/ISBN: 0032-6518 PMID: 4393788 Document Number: 24918
Document emailed within 1 workday
Related Documents
O'Callaghan, J.P.; Jensen, K.F. 1992: Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity Neurotoxicology 13(1): 113-122Campieri, M.; Gionchetti, P.; Belluzzi, A.; Brignola, C.; Tabanelli, G.M.; Forresan, F.; Miglioli, M.; Barbara, L. 1988: Sulphasalazine and new related compounds Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 9(4): 179-183
Bax, D.E.; Greaves, M.S.; Amos, R.S. 1986: Sulphasalazine treatment in rheumatoid arthritis Journal of Rheumatology 13(2): 463-464
Moore, P.K.; Hussaini, I.; Bhardwaj, R. 1988: Sulphasalazine increases fibrinolysis in the anaesthetised rat Thrombosis and Haemostasis 60(1): 121
Islam, M.N.; Alam, M.N.; Haq, S.A.; Moyenuzzaman, M.; Patwary, M.I.; Rahman, M.H. 2000: Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis Bangladesh Medical Research Council Bulletin 26(1): 1-7
Sansom, J.; Barnett, K.C.; Long, R.D. 1985: Keratoconjunctivitis sicca in the dog associated with the administration of salicylazosulphapyridine (sulphasalazine) Veterinary Record 116(15): 391-393
Burke, D.A.; Axon, A.T. 1987: Clostridium difficile, sulphasalazine, and ulcerative colitis Postgraduate Medical Journal 63(745): 955-957
Ragni, G.; Bestetti, O.; Lombardi, C.; Wyssling, H.; Di Pietro, R. 1983: Male infertility due to sulphasalazine therapy of ulcerous colitis Acta Europaea Fertilitatis 14(3): 223-226
Keso, L.; Kaarela, K.; Oksanen, K.; Ahonen, M. 1998: Thrombocytopenia in a patient with rheumatoid arthritis during sulphasalazine therapy Duodecim; Laaketieteellinen Aikakauskirja 114(17): 1731-1733
Sawyer, A.; Walker, T.M.; Terry, S.I. 1978: Behçet's syndrome with ileal involvement--the beneficial effect of sulphasalazine West Indian Medical Journal 27(4): 218-221
Varbanova, B.B.; Dyankov, E.D. 1999: Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis Advances in Experimental Medicine and Biology 455: 331-336
Shenoy, P.; Misra, R.; Jain, M.; Agarwal, V. 2008: Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome New Zealand Medical Journal 121(1276): 102-105
Corey, A.E.; Rose, G.M.; Conklin, J.D. 1990: Bioavailability of single and multiple doses of enteric-coated mesalamine and sulphasalazine Journal of International Medical Research 18(6): 441-453
Rachwał-Siek, K.; Ponikowska, M.; Wiland, P. 2011: Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report Wiadomosci Lekarskie 64(4): 283-287
Pullar, T.; Hunter, J.A.; Capell, H.A. 1985: Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy British Journal of Rheumatology 24(3): 269-276
Georgescu, C. 1992: Sulphasalazine therapy in rheumatoid arthritis. a two-year study and follow-up of clinical results Romanian Journal of Internal Medicine 30(2): 127-132
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76
Dawes, P.T.; Sheeran, T.P.; Fowler, P.D.; Shadforth, M.F. 1987: Improving the response to gold or D-penicillamine by addition of sulphasalazine. a pilot study in 25 patients with rheumatoid arthritis Clinical and Experimental Rheumatology 5(2): 151-153
Davis, M.J.; Dawes, P.T.; Beswick, E.; Lewin, I.V.; Stanworth, D.R. 1989: Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin British Journal of Rheumatology 28(5): 410-413
1990: Cisplatin neurotoxicity New England Journal of Medicine 323(1): 64-65